List of Excipients in API MEDROXYPROGESTERONE ACETATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing MEDROXYPROGESTERONE ACETATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pharmacia & Upjohn Company LLC | PROVERA | medroxyprogesterone acetate | 0009-0064 | CALCIUM STEARATE | |
| Pharmacia & Upjohn Company LLC | PROVERA | medroxyprogesterone acetate | 0009-0064 | FD&C YELLOW NO. 6 | |
| Pharmacia & Upjohn Company LLC | PROVERA | medroxyprogesterone acetate | 0009-0064 | LACTOSE | |
| Pharmacia & Upjohn Company LLC | PROVERA | medroxyprogesterone acetate | 0009-0064 | MINERAL OIL | |
| Pharmacia & Upjohn Company LLC | PROVERA | medroxyprogesterone acetate | 0009-0064 | SORBIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing MEDROXYPROGESTERONE ACETATE
Detailed excipient profiles for MEDROXYPROGESTERONE ACETATE
Excipient focus: CALCIUM STEARATE
MEDROXYPROGESTERONE ACETATE drug variants containing CALCIUM STEARATE
MEDROXYPROGESTERONE ACETATE drug variants not containing CALCIUM STEARATE
Excipient focus: CROSPOVIDONE
MEDROXYPROGESTERONE ACETATE drug variants containing CROSPOVIDONE
MEDROXYPROGESTERONE ACETATE drug variants not containing CROSPOVIDONE
Excipient focus: FD&C YELLOW NO. 6
MEDROXYPROGESTERONE ACETATE drug variants containing FD&C YELLOW NO. 6
MEDROXYPROGESTERONE ACETATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROCHLORIC ACID
MEDROXYPROGESTERONE ACETATE drug variants containing HYDROCHLORIC ACID
MEDROXYPROGESTERONE ACETATE drug variants not containing HYDROCHLORIC ACID
Excipient focus: LACTOSE
MEDROXYPROGESTERONE ACETATE drug variants containing LACTOSE
MEDROXYPROGESTERONE ACETATE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
MEDROXYPROGESTERONE ACETATE drug variants containing LACTOSE MONOHYDRATE
MEDROXYPROGESTERONE ACETATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
MEDROXYPROGESTERONE ACETATE drug variants containing MAGNESIUM STEARATE
MEDROXYPROGESTERONE ACETATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHIONINE
MEDROXYPROGESTERONE ACETATE drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | medroxyprogesterone acetate | 0009-4709 |
| >Company | >Ingredient | >NDC |
MEDROXYPROGESTERONE ACETATE drug variants not containing METHIONINE
Excipient focus: METHYLCELLULOSE
MEDROXYPROGESTERONE ACETATE drug variants containing METHYLCELLULOSE
MEDROXYPROGESTERONE ACETATE drug variants not containing METHYLCELLULOSE
Excipient focus: METHYLPARABEN
MEDROXYPROGESTERONE ACETATE drug variants containing METHYLPARABEN
MEDROXYPROGESTERONE ACETATE drug variants not containing METHYLPARABEN
Excipient focus: MINERAL OIL
MEDROXYPROGESTERONE ACETATE drug variants containing MINERAL OIL
MEDROXYPROGESTERONE ACETATE drug variants not containing MINERAL OIL
Excipient focus: POLYETHYLENE GLYCOL
MEDROXYPROGESTERONE ACETATE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | medroxyprogesterone acetate | 0009-4709 |
| >Company | >Ingredient | >NDC |
MEDROXYPROGESTERONE ACETATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
MEDROXYPROGESTERONE ACETATE drug variants containing POLYETHYLENE GLYCOL 3350
MEDROXYPROGESTERONE ACETATE drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYSORBATE 80
MEDROXYPROGESTERONE ACETATE drug variants containing POLYSORBATE 80
MEDROXYPROGESTERONE ACETATE drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
MEDROXYPROGESTERONE ACETATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | medroxyprogesterone acetate | 0009-4709 |
| >Company | >Ingredient | >NDC |
MEDROXYPROGESTERONE ACETATE drug variants not containing POVIDONE
Excipient focus: PROPYLPARABEN
MEDROXYPROGESTERONE ACETATE drug variants containing PROPYLPARABEN
MEDROXYPROGESTERONE ACETATE drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
MEDROXYPROGESTERONE ACETATE drug variants containing SODIUM CHLORIDE
MEDROXYPROGESTERONE ACETATE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
MEDROXYPROGESTERONE ACETATE drug variants containing SODIUM HYDROXIDE
MEDROXYPROGESTERONE ACETATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
MEDROXYPROGESTERONE ACETATE drug variants containing SODIUM LAURYL SULFATE
MEDROXYPROGESTERONE ACETATE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
MEDROXYPROGESTERONE ACETATE drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | medroxyprogesterone acetate | 0009-4709 |
| >Company | >Ingredient | >NDC |
MEDROXYPROGESTERONE ACETATE drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
MEDROXYPROGESTERONE ACETATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | medroxyprogesterone acetate | 0009-4709 |
| >Company | >Ingredient | >NDC |
MEDROXYPROGESTERONE ACETATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Excipient focus: SODIUM SULFATE ANHYDROUS
MEDROXYPROGESTERONE ACETATE drug variants containing SODIUM SULFATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | medroxyprogesterone acetate | 54868-3348 |
| >Company | >Ingredient | >NDC |
MEDROXYPROGESTERONE ACETATE drug variants not containing SODIUM SULFATE ANHYDROUS
Excipient focus: SORBIC ACID
MEDROXYPROGESTERONE ACETATE drug variants containing SORBIC ACID
MEDROXYPROGESTERONE ACETATE drug variants not containing SORBIC ACID
Excipient focus: STARCH, CORN
MEDROXYPROGESTERONE ACETATE drug variants containing STARCH, CORN
MEDROXYPROGESTERONE ACETATE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
MEDROXYPROGESTERONE ACETATE drug variants containing SUCROSE
MEDROXYPROGESTERONE ACETATE drug variants not containing SUCROSE
Excipient focus: TALC
MEDROXYPROGESTERONE ACETATE drug variants containing TALC
MEDROXYPROGESTERONE ACETATE drug variants not containing TALC
Excipient focus: WATER
MEDROXYPROGESTERONE ACETATE drug variants containing WATER
MEDROXYPROGESTERONE ACETATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
